Benjamin Landry, General Counsel at Health Catalyst, Inc. (HCAT), sold 2,500 shares at $7.52 ($19K) on 2025-01-06, disclosed to the SEC on 2025-01-10.
Scheduled sale ($19k) by General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| HCAT | SELL | 2025-06-09 | $24K | — | Filing → |
| HCAT | SELL | 2025-03-10 | $126K | — | Filing → |
| HCAT | SELL | 2024-12-10 | $321K | — | Filing → |